The Drug Development Journey for New Cancer Treatments - Part 2
Offered By: Imperial College London via YouTube
Course Description
Overview
Explore the second part of a 17-minute webinar presented by Professor Nick Turner, a renowned expert in breast cancer research and treatment. Delve into clinical studies on AKT inhibitors as part of the drug development journey for new cancer treatments. Gain insights from Turner's role as Team Leader at the Breast Cancer Now Toby Robins Research Centre and his experience as a Consultant Medical Oncologist at the Royal Marsden Hospital. Learn about cutting-edge research in cancer drug development and its potential impact on patient care. For a comprehensive understanding, view the first part of this presentation available through the provided link. Discover more about this research and related topics by visiting the official website of the Academic Health Science Centre.
Syllabus
The drug development journey for new cancer treatments – Prof. Nick Turner (Part 2 of 2)
Taught by
Imperial College London
Related Courses
Good Pharmacy Practice: Medication ManagementTaipei Medical University via FutureLearn Good Pharmacy Practice: Pharmaceutical Services
Taipei Medical University via FutureLearn Capstone Project: Advanced AI for Drug Discovery
LearnQuest via Coursera Anticoagulación
Universidad de los Andes via Coursera Antimicrobial Stewardship: Improving Clinical Outcomes by Optimization of Antibiotic Practices
Stanford University via Independent